
### [MONDO:0020282](http://purl.obolibrary.org/obo/MONDO_0020282)
**Label:** metabolic disease with macular cherry-red spot

**Subclasses:** [MONDO:0017721](http://purl.obolibrary.org/obo/MONDO_0017721) (Sandhoff disease, infantile form), [MONDO:0009260](http://purl.obolibrary.org/obo/MONDO_0009260) (GM1 gangliosidosis type 1), [MONDO:0009261](http://purl.obolibrary.org/obo/MONDO_0009261) (GM1 gangliosidosis type 2), [MONDO:0018149](http://purl.obolibrary.org/obo/MONDO_0018149) (GM1 gangliosidosis), [MONDO:0017723](http://purl.obolibrary.org/obo/MONDO_0017723) (Sandhoff disease, adult form), [MONDO:0009262](http://purl.obolibrary.org/obo/MONDO_0009262) (GM1 gangliosidosis type 3), [MONDO:0017722](http://purl.obolibrary.org/obo/MONDO_0017722) (Sandhoff disease, juvenile form), [MONDO:0019346](http://purl.obolibrary.org/obo/MONDO_0019346) (sialidosis type 1), [MONDO:0010100](http://purl.obolibrary.org/obo/MONDO_0010100) (Tay-Sachs disease), [MONDO:0009756](http://purl.obolibrary.org/obo/MONDO_0009756) (Niemann-Pick disease type A), [MONDO:0009737](http://purl.obolibrary.org/obo/MONDO_0009737) (Galactosialidosis), [MONDO:0017728](http://purl.obolibrary.org/obo/MONDO_0017728) (Tay-Sachs disease, B1 variant), [MONDO:0017725](http://purl.obolibrary.org/obo/MONDO_0017725) (Tay-Sachs disease, b variant, juvenile form), [MONDO:0017724](http://purl.obolibrary.org/obo/MONDO_0017724) (Tay-Sachs disease, b variant, infantile form), [MONDO:0010006](http://purl.obolibrary.org/obo/MONDO_0010006) (Sandhoff disease), [MONDO:0017726](http://purl.obolibrary.org/obo/MONDO_0017726) (Tay-Sachs disease, b variant, adult form), 

**Mapped go classes:** [GO:0019915](http://purl.obolibrary.org/obo/GO_0019915) (lipid storage), [GO:0004180](http://purl.obolibrary.org/obo/GO_0004180) (carboxypeptidase activity), [GO:0006685](http://purl.obolibrary.org/obo/GO_0006685) (sphingomyelin catabolic process), [GO:0004185](http://purl.obolibrary.org/obo/GO_0004185) (serine-type carboxypeptidase activity), [GO:0009313](http://purl.obolibrary.org/obo/GO_0009313) (oligosaccharide catabolic process), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0006044](http://purl.obolibrary.org/obo/GO_0006044) (N-acetylglucosamine metabolic process), [GO:0006689](http://purl.obolibrary.org/obo/GO_0006689) (ganglioside catabolic process), [GO:0007338](http://purl.obolibrary.org/obo/GO_0007338) (single fertilization), [GO:0006687](http://purl.obolibrary.org/obo/GO_0006687) (glycosphingolipid metabolic process), [GO:0007605](http://purl.obolibrary.org/obo/GO_0007605) (sensory perception of sound), [GO:0023021](http://purl.obolibrary.org/obo/GO_0023021) (termination of signal transduction), [GO:0001501](http://purl.obolibrary.org/obo/GO_0001501) (skeletal system development), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0001669](http://purl.obolibrary.org/obo/GO_0001669) (acrosomal vesicle), [GO:0042582](http://purl.obolibrary.org/obo/GO_0042582) (azurophil granule), [GO:0051603](http://purl.obolibrary.org/obo/GO_0051603) (proteolysis involved in cellular protein catabolic process), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0007341](http://purl.obolibrary.org/obo/GO_0007341) (penetration of zona pellucida), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0060395](http://purl.obolibrary.org/obo/GO_0060395) (SMAD protein signal transduction), [GO:0042220](http://purl.obolibrary.org/obo/GO_0042220) (response to cocaine), [GO:0008233](http://purl.obolibrary.org/obo/GO_0008233) (peptidase activity), [GO:0004553](http://purl.obolibrary.org/obo/GO_0004553) (hydrolase activity, hydrolyzing O-glycosyl compounds), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005764](http://purl.obolibrary.org/obo/GO_0005764) (lysosome), [GO:0050884](http://purl.obolibrary.org/obo/GO_0050884) (neuromuscular process controlling posture), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0035307](http://purl.obolibrary.org/obo/GO_0035307) (positive regulation of protein dephosphorylation), [GO:0019953](http://purl.obolibrary.org/obo/GO_0019953) (sexual reproduction), [GO:0050885](http://purl.obolibrary.org/obo/GO_0050885) (neuromuscular process controlling balance), [GO:0008360](http://purl.obolibrary.org/obo/GO_0008360) (regulation of cell shape), [GO:0061750](http://purl.obolibrary.org/obo/GO_0061750) (acid sphingomyelin phosphodiesterase activity), [GO:0043407](http://purl.obolibrary.org/obo/GO_0043407) (negative regulation of MAP kinase activity), [GO:0006024](http://purl.obolibrary.org/obo/GO_0006024) (glycosaminoglycan biosynthetic process), [GO:0008049](http://purl.obolibrary.org/obo/GO_0008049) (male courtship behavior), [GO:0046513](http://purl.obolibrary.org/obo/GO_0046513) (ceramide biosynthetic process), [GO:0042552](http://purl.obolibrary.org/obo/GO_0042552) (myelination), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0005773](http://purl.obolibrary.org/obo/GO_0005773) (vacuole), [GO:0004563](http://purl.obolibrary.org/obo/GO_0004563) (beta-N-acetylhexosaminidase activity), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0042599](http://purl.obolibrary.org/obo/GO_0042599) (lamellar body), [GO:1904715](http://purl.obolibrary.org/obo/GO_1904715) (negative regulation of chaperone-mediated autophagy), [GO:0004565](http://purl.obolibrary.org/obo/GO_0004565) (beta-galactosidase activity), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0007628](http://purl.obolibrary.org/obo/GO_0007628) (adult walking behavior), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0007626](http://purl.obolibrary.org/obo/GO_0007626) (locomotory behavior), [GO:0005768](http://purl.obolibrary.org/obo/GO_0005768) (endosome), [GO:0044262](http://purl.obolibrary.org/obo/GO_0044262) (cellular carbohydrate metabolic process), [GO:0015929](http://purl.obolibrary.org/obo/GO_0015929) (hexosaminidase activity), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:0019388](http://purl.obolibrary.org/obo/GO_0019388) (galactose catabolic process), [GO:0016231](http://purl.obolibrary.org/obo/GO_0016231) (beta-N-acetylglucosaminidase activity), [GO:0030246](http://purl.obolibrary.org/obo/GO_0030246) (carbohydrate binding), [GO:0016798](http://purl.obolibrary.org/obo/GO_0016798) (hydrolase activity, acting on glycosyl bonds), [GO:0030203](http://purl.obolibrary.org/obo/GO_0030203) (glycosaminoglycan metabolic process), [GO:0043615](http://purl.obolibrary.org/obo/GO_0043615) (astrocyte cell migration), [GO:0007040](http://purl.obolibrary.org/obo/GO_0007040) (lysosome organization), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0008375](http://purl.obolibrary.org/obo/GO_0008375) (acetylglucosaminyltransferase activity), [GO:0016936](http://purl.obolibrary.org/obo/GO_0016936) (galactoside binding), [GO:0050905](http://purl.obolibrary.org/obo/GO_0050905) (neuromuscular process), [GO:0044267](http://purl.obolibrary.org/obo/GO_0044267) (cellular protein metabolic process), [GO:0008654](http://purl.obolibrary.org/obo/GO_0008654) (phospholipid biosynthetic process), [GO:0048667](http://purl.obolibrary.org/obo/GO_0048667) (cell morphogenesis involved in neuron differentiation), [GO:0006874](http://purl.obolibrary.org/obo/GO_0006874) (cellular calcium ion homeostasis), [GO:0005975](http://purl.obolibrary.org/obo/GO_0005975) (carbohydrate metabolic process), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0004767](http://purl.obolibrary.org/obo/GO_0004767) (sphingomyelin phosphodiesterase activity), [GO:0031647](http://purl.obolibrary.org/obo/GO_0031647) (regulation of protein stability), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0048477](http://purl.obolibrary.org/obo/GO_0048477) (oogenesis), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0006508](http://purl.obolibrary.org/obo/GO_0006508) (proteolysis), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0031323](http://purl.obolibrary.org/obo/GO_0031323) (regulation of cellular metabolic process), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- Thing 53.13%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 52.08%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 52.08%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 37.44%
- [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle) and [GO:0043230](http://purl.obolibrary.org/obo/GO_0043230) (extracellular organelle) 37.44%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0007574](http://purl.obolibrary.org/obo/GO_0007574) (obsolete cell aging (sensu Saccharomyces))) 37.44%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0007573](http://purl.obolibrary.org/obo/GO_0007573) (obsolete age dependent increased protein content)) 37.44%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0007572](http://purl.obolibrary.org/obo/GO_0007572) (obsolete age dependent decreased translational activity)) 37.44%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0007570](http://purl.obolibrary.org/obo/GO_0007570) (obsolete age dependent accumulation of genetic damage)) 37.44%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0007559](http://purl.obolibrary.org/obo/GO_0007559) (obsolete histolysis)) 37.44%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0007551](http://purl.obolibrary.org/obo/GO_0007551) (obsolete maintenance of dosage compensation)) 37.44%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0007550](http://purl.obolibrary.org/obo/GO_0007550) (obsolete establishment of dosage compensation)) 37.44%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0007544](http://purl.obolibrary.org/obo/GO_0007544) (null)) 37.44%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0007515](http://purl.obolibrary.org/obo/GO_0007515) (obsolete lymph gland development)) 37.44%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0007514](http://purl.obolibrary.org/obo/GO_0007514) (null)) 37.44%


